 | • レポートコード：D0804-01561 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、103ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ビカルタミドの世界市場を広く調査・分析し、今後の市場展望をまとめております。ビカルタミドの種類別市場規模（錠剤、カプセル）、用途別市場規模（前立腺がん用単一薬物、前立腺がん用複合化学療法、前立腺がん用複合放射・去勢）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AstraZeneca、ANI Pharmaceuticals、Actavis Pharma、CORDEN PHARMA GMBH、Fresenius Kabi、Zeneca GmbH、Apotex Corporation、Sorres Pharma、Sivem Pharmaceuticals、Accel Pharma、Shanghai Fudan Fuhua Pharmaceutical、Shanxi Zhendong Pharmaceutical、Shanghai Zhaohui Pharmaceutical、Zhejiang Haizheng Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・ビカルタミドの北米市場（アメリカ、カナダ、メキシコ） ・ビカルタミドのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ビカルタミドのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ビカルタミドの南米市場（ブラジル、アルゼンチン） ・ビカルタミドの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：錠剤、カプセル ・用途別分析：前立腺がん用単一薬物、前立腺がん用複合化学療法、前立腺がん用複合放射・去勢 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Bicalutamide market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Bicalutamide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Bicalutamide market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Bicalutamide market has been segmented into
Tablets
Capsule
By Application, Bicalutamide has been segmented into:
Single Drug For Prostate Cancer
Combined Chemotherapy For Prostate Cancer
Combined Radiation Therapy Or Castration For Prostate Cancer
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Bicalutamide market presented in the report. This section sheds light on the sales growth of different regional and country-level Bicalutamide markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Bicalutamide market.
The report offers in-depth assessment of the growth and other aspects of the Bicalutamide market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Bicalutamide Market Share Analysis
Bicalutamide competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Bicalutamide sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Bicalutamide sales, revenue and market share for each player covered in this report.
The major players covered in Bicalutamide are:
AstraZeneca
ANI Pharmaceuticals
Actavis Pharma
CORDEN PHARMA GMBH
Fresenius Kabi
Zeneca GmbH
Apotex Corporation
Sorres Pharma
Sivem Pharmaceuticals
Accel Pharma
Shanghai Fudan Fuhua Pharmaceutical
Shanxi Zhendong Pharmaceutical
Shanghai Zhaohui Pharmaceutical
Zhejiang Haizheng Pharmaceutical
Among other players domestic and global, Bicalutamide market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bicalutamide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bicalutamide, with price, sales, revenue and global market share of Bicalutamide in 2018 and 2019.
Chapter 3, the Bicalutamide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bicalutamide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Bicalutamide market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Bicalutamide sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Bicalutamide Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bicalutamide Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Tablets
1.2.3 Capsule
1.3 Market Analysis by Application
1.3.1 Overview: Global Bicalutamide Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Single Drug For Prostate Cancer
1.3.3 Combined Chemotherapy For Prostate Cancer
1.3.4 Combined Radiation Therapy Or Castration For Prostate Cancer
1.4 Overview of Global Bicalutamide Market
1.4.1 Global Bicalutamide Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 ANI Pharmaceuticals
2.2.1 ANI Pharmaceuticals Details
2.2.2 ANI Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 ANI Pharmaceuticals SWOT Analysis
2.2.4 ANI Pharmaceuticals Product and Services
2.2.5 ANI Pharmaceuticals Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Actavis Pharma
2.3.1 Actavis Pharma Details
2.3.2 Actavis Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Actavis Pharma SWOT Analysis
2.3.4 Actavis Pharma Product and Services
2.3.5 Actavis Pharma Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 CORDEN PHARMA GMBH
2.4.1 CORDEN PHARMA GMBH Details
2.4.2 CORDEN PHARMA GMBH Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 CORDEN PHARMA GMBH SWOT Analysis
2.4.4 CORDEN PHARMA GMBH Product and Services
2.4.5 CORDEN PHARMA GMBH Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Fresenius Kabi
2.5.1 Fresenius Kabi Details
2.5.2 Fresenius Kabi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Fresenius Kabi SWOT Analysis
2.5.4 Fresenius Kabi Product and Services
2.5.5 Fresenius Kabi Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Zeneca GmbH
2.6.1 Zeneca GmbH Details
2.6.2 Zeneca GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Zeneca GmbH SWOT Analysis
2.6.4 Zeneca GmbH Product and Services
2.6.5 Zeneca GmbH Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Apotex Corporation
2.7.1 Apotex Corporation Details
2.7.2 Apotex Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Apotex Corporation SWOT Analysis
2.7.4 Apotex Corporation Product and Services
2.7.5 Apotex Corporation Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sorres Pharma
2.8.1 Sorres Pharma Details
2.8.2 Sorres Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sorres Pharma SWOT Analysis
2.8.4 Sorres Pharma Product and Services
2.8.5 Sorres Pharma Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sivem Pharmaceuticals
2.9.1 Sivem Pharmaceuticals Details
2.9.2 Sivem Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sivem Pharmaceuticals SWOT Analysis
2.9.4 Sivem Pharmaceuticals Product and Services
2.9.5 Sivem Pharmaceuticals Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Accel Pharma
2.10.1 Accel Pharma Details
2.10.2 Accel Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Accel Pharma SWOT Analysis
2.10.4 Accel Pharma Product and Services
2.10.5 Accel Pharma Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Shanghai Fudan Fuhua Pharmaceutical
2.11.1 Shanghai Fudan Fuhua Pharmaceutical Details
2.11.2 Shanghai Fudan Fuhua Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Shanghai Fudan Fuhua Pharmaceutical SWOT Analysis
2.11.4 Shanghai Fudan Fuhua Pharmaceutical Product and Services
2.11.5 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Shanxi Zhendong Pharmaceutical
2.12.1 Shanxi Zhendong Pharmaceutical Details
2.12.2 Shanxi Zhendong Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Shanxi Zhendong Pharmaceutical SWOT Analysis
2.12.4 Shanxi Zhendong Pharmaceutical Product and Services
2.12.5 Shanxi Zhendong Pharmaceutical Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Shanghai Zhaohui Pharmaceutical
2.13.1 Shanghai Zhaohui Pharmaceutical Details
2.13.2 Shanghai Zhaohui Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Shanghai Zhaohui Pharmaceutical SWOT Analysis
2.13.4 Shanghai Zhaohui Pharmaceutical Product and Services
2.13.5 Shanghai Zhaohui Pharmaceutical Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Zhejiang Haizheng Pharmaceutical
2.14.1 Zhejiang Haizheng Pharmaceutical Details
2.14.2 Zhejiang Haizheng Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Zhejiang Haizheng Pharmaceutical SWOT Analysis
2.14.4 Zhejiang Haizheng Pharmaceutical Product and Services
2.14.5 Zhejiang Haizheng Pharmaceutical Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Bicalutamide Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Bicalutamide Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Bicalutamide Manufacturer Market Share in 2019
3.3.2 Top 6 Bicalutamide Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Bicalutamide Sales, Revenue and Market Share by Regions
4.1.1 Global Bicalutamide Sales and Market Share by Regions (2015-2020)
4.1.2 Global Bicalutamide Revenue and Market Share by Regions (2015-2020)
4.2 North America Bicalutamide Sales and Growth Rate (2015-2020)
4.3 Europe Bicalutamide Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Bicalutamide Sales and Growth Rate (2015-2020)
4.5 South America Bicalutamide Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Bicalutamide Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Bicalutamide Sales, Revenue and Market Share by Country
5.1.1 North America Bicalutamide Sales and Market Share by Country (2015-2020)
5.1.2 North America Bicalutamide Revenue and Market Share by Country (2015-2020)
5.2 United States Bicalutamide Sales and Growth Rate (2015-2020)
5.3 Canada Bicalutamide Sales and Growth Rate (2015-2020)
5.4 Mexico Bicalutamide Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Bicalutamide Sales, Revenue and Market Share by Country
6.1.1 Europe Bicalutamide Sales and Market Share by Country (2015-2020)
6.1.2 Europe Bicalutamide Revenue and Market Share by Country (2015-2020)
6.2 Germany Bicalutamide Sales and Growth Rate (2015-2020)
6.3 UK Bicalutamide Sales and Growth Rate (2015-2020)
6.4 France Bicalutamide Sales and Growth Rate (2015-2020)
6.5 Russia Bicalutamide Sales and Growth Rate (2015-2020)
6.6 Italy Bicalutamide Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Bicalutamide Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Bicalutamide Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Bicalutamide Revenue and Market Share by Regions (2015-2020)
7.2 China Bicalutamide Sales and Growth Rate (2015-2020)
7.3 Japan Bicalutamide Sales and Growth Rate (2015-2020)
7.4 Korea Bicalutamide Sales and Growth Rate (2015-2020)
7.5 India Bicalutamide Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Bicalutamide Sales and Growth Rate (2015-2020)
7.7 Australia Bicalutamide Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Bicalutamide Sales, Revenue and Market Share by Country
8.1.1 South America Bicalutamide Sales and Market Share by Country (2015-2020)
8.1.2 South America Bicalutamide Revenue and Market Share by Country (2015-2020)
8.2 Brazil Bicalutamide Sales and Growth Rate (2015-2020)
8.3 Argentina Bicalutamide Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Bicalutamide Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Bicalutamide Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Bicalutamide Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Bicalutamide Sales and Growth Rate (2015-2020)
9.3 Turkey Bicalutamide Sales and Growth Rate (2015-2020)
9.4 Egypt Bicalutamide Sales and Growth Rate (2015-2020)
9.5 South Africa Bicalutamide Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Bicalutamide Sales and Market Share by Type (2015-2020)
10.2 Global Bicalutamide Revenue and Market Share by Type (2015-2020)
10.3 Global Bicalutamide Price by Type (2015-2020)
11 Global Bicalutamide Market Segment by Application
11.1 Global Bicalutamide Sales Market Share by Application (2015-2020)
11.2 Global Bicalutamide Revenue Market Share by Application (2015-2020)
11.3 Global Bicalutamide Price by Application (2015-2020)
12 Market Forecast
12.1 Global Bicalutamide Sales, Revenue and Growth Rate (2021-2025)
12.2 Bicalutamide Market Forecast by Regions (2021-2025)
12.2.1 North America Bicalutamide Market Forecast (2021-2025)
12.2.2 Europe Bicalutamide Market Forecast (2021-2025)
12.2.3 Asia-Pacific Bicalutamide Market Forecast (2021-2025)
12.2.4 South America Bicalutamide Market Forecast (2021-2025)
12.2.5 Middle East & Africa Bicalutamide Market Forecast (2021-2025)
12.3 Bicalutamide Market Forecast by Type (2021-2025)
12.3.1 Global Bicalutamide Sales Forecast by Type (2021-2025)
12.3.2 Global Bicalutamide Market Share Forecast by Type (2021-2025)
12.4 Bicalutamide Market Forecast by Application (2021-2025)
12.4.1 Global Bicalutamide Sales Forecast by Application (2021-2025)
12.4.2 Global Bicalutamide Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Bicalutamide Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Bicalutamide by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Bicalutamide Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Bicalutamide Major Business
Table 9. AstraZeneca Bicalutamide Total Revenue (USD Million) (2018-2019)
Table 10. AstraZeneca SWOT Analysis
Table 11. AstraZeneca Bicalutamide Product and Services
Table 12. AstraZeneca Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. ANI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. ANI Pharmaceuticals Bicalutamide Major Business
Table 15. ANI Pharmaceuticals Bicalutamide Total Revenue (USD Million) (2018-2019)
Table 16. ANI Pharmaceuticals SWOT Analysis
Table 17. ANI Pharmaceuticals Bicalutamide Product and Services
Table 18. ANI Pharmaceuticals Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Actavis Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Actavis Pharma Bicalutamide Major Business
Table 21. Actavis Pharma Bicalutamide Total Revenue (USD Million) (2018-2019)
Table 22. Actavis Pharma SWOT Analysis
Table 23. Actavis Pharma Bicalutamide Product and Services
Table 24. Actavis Pharma Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. CORDEN PHARMA GMBH Basic Information, Manufacturing Base and Competitors
Table 26. CORDEN PHARMA GMBH Bicalutamide Major Business
Table 27. CORDEN PHARMA GMBH Bicalutamide Total Revenue (USD Million) (2018-2019)
Table 28. CORDEN PHARMA GMBH SWOT Analysis
Table 29. CORDEN PHARMA GMBH Bicalutamide Product and Services
Table 30. CORDEN PHARMA GMBH Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 32. Fresenius Kabi Bicalutamide Major Business
Table 33. Fresenius Kabi Bicalutamide Total Revenue (USD Million) (2018-2019)
Table 34. Fresenius Kabi SWOT Analysis
Table 35. Fresenius Kabi Bicalutamide Product and Services
Table 36. Fresenius Kabi Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Zeneca GmbH Basic Information, Manufacturing Base and Competitors
Table 38. Zeneca GmbH Bicalutamide Major Business
Table 39. Zeneca GmbH Bicalutamide Total Revenue (USD Million) (2018-2019)
Table 40. Zeneca GmbH SWOT Analysis
Table 41. Zeneca GmbH Bicalutamide Product and Services
Table 42. Zeneca GmbH Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Apotex Corporation Basic Information, Manufacturing Base and Competitors
Table 44. Apotex Corporation Bicalutamide Major Business
Table 45. Apotex Corporation Bicalutamide Total Revenue (USD Million) (2018-2019)
Table 46. Apotex Corporation SWOT Analysis
Table 47. Apotex Corporation Bicalutamide Product and Services
Table 48. Apotex Corporation Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Sorres Pharma Basic Information, Manufacturing Base and Competitors
Table 50. Sorres Pharma Bicalutamide Major Business
Table 51. Sorres Pharma Bicalutamide Total Revenue (USD Million) (2018-2019)
Table 52. Sorres Pharma SWOT Analysis
Table 53. Sorres Pharma Bicalutamide Product and Services
Table 54. Sorres Pharma Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Sivem Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Sivem Pharmaceuticals Bicalutamide Major Business
Table 57. Sivem Pharmaceuticals Bicalutamide Total Revenue (USD Million) (2018-2019)
Table 58. Sivem Pharmaceuticals SWOT Analysis
Table 59. Sivem Pharmaceuticals Bicalutamide Product and Services
Table 60. Sivem Pharmaceuticals Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Accel Pharma Basic Information, Manufacturing Base and Competitors
Table 62. Accel Pharma Bicalutamide Major Business
Table 63. Accel Pharma Bicalutamide Total Revenue (USD Million) (2018-2019)
Table 64. Accel Pharma SWOT Analysis
Table 65. Accel Pharma Bicalutamide Product and Services
Table 66. Accel Pharma Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Shanghai Fudan Fuhua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Major Business
Table 69. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Total Revenue (USD Million) (2018-2019)
Table 70. Shanghai Fudan Fuhua Pharmaceutical SWOT Analysis
Table 71. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Product and Services
Table 72. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Shanxi Zhendong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Shanxi Zhendong Pharmaceutical Bicalutamide Major Business
Table 75. Shanxi Zhendong Pharmaceutical Bicalutamide Total Revenue (USD Million) (2018-2019)
Table 76. Shanxi Zhendong Pharmaceutical SWOT Analysis
Table 77. Shanxi Zhendong Pharmaceutical Bicalutamide Product and Services
Table 78. Shanxi Zhendong Pharmaceutical Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Shanghai Zhaohui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Shanghai Zhaohui Pharmaceutical Bicalutamide Major Business
Table 81. Shanghai Zhaohui Pharmaceutical Bicalutamide Total Revenue (USD Million) (2018-2019)
Table 82. Shanghai Zhaohui Pharmaceutical SWOT Analysis
Table 83. Shanghai Zhaohui Pharmaceutical Bicalutamide Product and Services
Table 84. Shanghai Zhaohui Pharmaceutical Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Zhejiang Haizheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 86. Zhejiang Haizheng Pharmaceutical Bicalutamide Major Business
Table 87. Zhejiang Haizheng Pharmaceutical Bicalutamide Total Revenue (USD Million) (2018-2019)
Table 88. Zhejiang Haizheng Pharmaceutical SWOT Analysis
Table 89. Zhejiang Haizheng Pharmaceutical Bicalutamide Product and Services
Table 90. Zhejiang Haizheng Pharmaceutical Bicalutamide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Global Bicalutamide Sales by Manufacturer (2018-2019) (M Pcs)
Table 92. Global Bicalutamide Revenue by Manufacturer (2018-2019) (USD Million)
Table 93. Global Bicalutamide Sales by Regions (2015-2020) (M Pcs)
Table 94. Global Bicalutamide Sales Market Share by Regions (2015-2020)
Table 95. Global Bicalutamide Revenue by Regions (2015-2020) (USD Million)
Table 96. North America Bicalutamide Sales by Countries (2015-2020) (M Pcs)
Table 97. North America Bicalutamide Sales Market Share by Countries (2015-2020)
Table 98. North America Bicalutamide Revenue by Countries (2015-2020) (USD Million)
Table 99. North America Bicalutamide Revenue Market Share by Countries (2015-2020)
Table 100. Europe Bicalutamide Sales by Countries (2015-2020) (M Pcs)
Table 101. Europe Bicalutamide Sales Market Share by Countries (2015-2020)
Table 102. Europe Bicalutamide Revenue by Countries (2015-2020) (USD Million)
Table 103. Asia-Pacific Bicalutamide Sales by Regions (2015-2020) (M Pcs)
Table 104. Asia-Pacific Bicalutamide Sales Market Share by Regions (2015-2020)
Table 105. Asia-Pacific Bicalutamide Revenue by Regions (2015-2020) (USD Million)
Table 106. South America Bicalutamide Sales by Countries (2015-2020) (M Pcs)
Table 107. South America Bicalutamide Sales Market Share by Countries (2015-2020)
Table 108. South America Bicalutamide Revenue by Countries (2015-2020) (USD Million)
Table 109. South America Bicalutamide Revenue Market Share by Countries (2015-2020)
Table 110. Middle East & Africa Bicalutamide Sales by Countries (2015-2020) (M Pcs)
Table 111. Middle East & Africa Bicalutamide Sales Market Share by Countries (2015-2020)
Table 112. Middle East & Africa Bicalutamide Revenue by Countries (2015-2020) (USD Million)
Table 113. Middle East & Africa Bicalutamide Revenue Market Share by Countries (2015-2020)
Table 114. Global Bicalutamide Sales by Type (2015-2020) (M Pcs)
Table 115. Global Bicalutamide Sales Share by Type (2015-2020)
Table 116. Global Bicalutamide Revenue by Type (2015-2020) (USD Million)
Table 117. Global Bicalutamide Revenue Share by Type (2015-2020)
Table 118. Global Bicalutamide Sales by Application (2015-2020) (M Pcs)
Table 119. Global Bicalutamide Sales Share by Application (2015-2020)
Table 120. Global Bicalutamide Sales Forecast by Regions (2021-2025) (M Pcs)
Table 121. Global Bicalutamide Market Share Forecast by Regions (2021-2025)
Table 122. Global Bicalutamide Sales Forecast by Type (2021-2025) (M Pcs)
Table 123. Global Bicalutamide Market Share Forecast by Type (2021-2025)
Table 124. Global Bicalutamide Sales Forecast by Application (2021-2025)
Table 125. Global Bicalutamide Market Share Forecast by Application (2021-2025)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Bicalutamide Picture
Figure 2. Global Sales Market Share of Bicalutamide by Type in 2019
Figure 3. Tablets Picture
Figure 4. Capsule Picture
Figure 5. Bicalutamide Sales Market Share by Application in 2018
Figure 6. Single Drug For Prostate Cancer Picture
Figure 7. Combined Chemotherapy For Prostate Cancer Picture
Figure 8. Combined Radiation Therapy Or Castration For Prostate Cancer Picture
Figure 9. Global Bicalutamide Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Bicalutamide Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Bicalutamide Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Bicalutamide Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Bicalutamide Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Bicalutamide Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Bicalutamide Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Bicalutamide Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Bicalutamide Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Bicalutamide Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Bicalutamide Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Bicalutamide Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Bicalutamide Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Bicalutamide Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Bicalutamide Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Bicalutamide Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Bicalutamide Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Bicalutamide Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Bicalutamide Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Bicalutamide Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Bicalutamide Sales Market Share by Manufacturer in 2019
Figure 30. Global Bicalutamide Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Bicalutamide Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Bicalutamide Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 35. Global Bicalutamide Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Bicalutamide Revenue Market Share by Regions (2015-2020)
Figure 37. Global Bicalutamide Revenue Market Share by Regions in 2018
Figure 38. North America Bicalutamide Sales and Growth Rate (2015-2020)
Figure 39. Europe Bicalutamide Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Bicalutamide Sales and Growth Rate (2015-2020)
Figure 41. South America Bicalutamide Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Bicalutamide Sales and Growth Rate (2015-2020)
Figure 43. North America Bicalutamide Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Bicalutamide Sales Market Share by Countries (2015-2020)
Figure 45. North America Bicalutamide Sales Market Share by Countries in 2018
Figure 46. North America Bicalutamide Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Bicalutamide Revenue Market Share by Countries in 2018
Figure 48. United States Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 49. Canada Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 50. Mexico Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 51. Europe Bicalutamide Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Bicalutamide Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Bicalutamide Revenue Market Share by Countries in 2019
Figure 54. Germany Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 55. UK Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 56. France Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 57. Russia Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 58. Italy Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 59. Asia-Pacific Bicalutamide Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Bicalutamide Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Bicalutamide Revenue Market Share by Regions 2019
Figure 62. China Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 63. Japan Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 64. Korea Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 65. India Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 66. Southeast Asia Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 67. South America Bicalutamide Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Bicalutamide Sales Market Share by Countries in 2019
Figure 69. South America Bicalutamide Revenue Market Share by Countries in 2019
Figure 70. Brazil Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 71. Argentina Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 72. Middle East and Africa Bicalutamide Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Bicalutamide Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Bicalutamide Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Bicalutamide Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 77. Egypt Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 78. Turkey Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 79. South Africa Bicalutamide Sales and Growth Rate (2015-2020) (M Pcs)
Figure 80. Global Bicalutamide Sales and Growth Rate (2021-2025) (M Pcs)
Figure 81. Global Bicalutamide Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Bicalutamide Market Forecast (2021-2025) (M Pcs)
Figure 83. Europe Sales Bicalutamide Market Forecast (2021-2025) (M Pcs)
Figure 84. Asia-Pacific Sales Bicalutamide Market Forecast (2021-2025) (M Pcs)
Figure 85. South America Sales Bicalutamide Market Forecast (2021-2025) (M Pcs)
Figure 86. Middle East & Africa Sales Bicalutamide Market Forecast (2021-2025) (M Pcs)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
前立腺生検装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Prostate Biopsy Equipment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prostate Biopsy Equ…- 転移性乳がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Metastatic Breast Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metastatic…
- 腫瘍溶解性ウイルスがん免疫療法の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Oncolytic Virus Cancer Immunotherapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oncolyti…
- がん検診技術の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Cancer Screening Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 骨がんの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Bone Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.8% in the forecast period of 2020 to 2025 and will expected to reach USD 65910 million by 2025, from USD 56730 million in 2019. The Bone Cancer market report …